Medicalgorithmics Stock

Medicalgorithmics Financing Cash Flow

The Net Financing Cash Flow of Medicalgorithmics (MDG.WA) as of Mar 20, 2026 is 447,000 PLN.In the previous year, Net Financing Cash Flow was -2.81 M PLN — a change of -115.91% (higher).

Financing Cash Flow

447,000PLN

YoY

-115.91%

Last updated:

Net Financing Cash Flow of Medicalgorithmics is 2026 447,000 PLN. Net Financing Cash Flow of Medicalgorithmics was 2025 -2.81 M PLN. It decreases by -115.91% higher compared to the previous year.
Access this data via the Eulerpool API

Medicalgorithmics Stock analysis

What does Medicalgorithmics do? Medicalgorithmics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicalgorithmics stock

Net Financing Cash Flow of Medicalgorithmics amounted to -2.81 M PLN 447,000

Access this data via the Eulerpool API

Cash Flow — Medicalgorithmics

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

All Key Metrics — Medicalgorithmics